Söring Surgery Holding, a specialist in ultrasonic surgery, has chosen a new majority shareholder to support its growth strategy. ConAlliance provided exclusive M&A advisory services to Söring Holding and its shareholder Anna Söring, successfully facilitating the share sale.
Söring is a pioneer and market leader in ultrasonic surgery. This technology has become integral to modern medicine, allowing practitioners to operate near highly sensitive structures or remove nonviable tissue with minimal impact on healthy or critical areas. Söring holds numerous patents for applications used in liver, spinal, and neurosurgery, as well as wound debridement. The company is renowned for its global installations in prestigious hospitals.
Founded in 1985 by Holger Söring and continued by his daughter Anna Söring, the company is headquartered in Quickborn, Germany. Söring has branches in the USA, Colombia, and Russia, and a global distribution network spanning more than 90 countries.
In close collaboration with leading surgeons, Söring continually optimizes and expands its extensive product range. All products are developed, manufactured, and distributed in-house, ensuring the highest quality and reliability for surgeons and operating teams worldwide. The durability and reusability of Söring products also enhance cost efficiency.
Söring generators are known for their high performance and longevity, while all instruments provide precise and ergonomic operation, supporting minimally invasive procedures.
Golden Light GmbH, an investment company, will become the new long-term partner and majority shareholder of Söring Holding GmbH.
ConAlliance is a leading M&A advisory firm, providing comprehensive support for corporate sales and acquisitions in the healthcare sector. Since its founding in 2011, ConAlliance has successfully managed over 100 mandates.
ConAlliance's expertise is highly specialized, focusing exclusively on corporate transactions within the healthcare industry. Core competencies include medical technology, medical products, pharmaceuticals, nursing and hospital care, healthcare IT, and other manufacturing and service companies in the global healthcare sector, as well as healthcare real estate.
Leadership of the ConAlliance Team
This transaction was led by Managing Partner Günter Carl Hober.
For more information about ConAlliance and our M&A advisory services, please visit www.conalliance.com.